Philip Morris International’s Revenue and Stock Jumps Due to IQOS

 

(Tobacco Business Magazine) Philip Morris International (PMI) can thank the emerging market of heat-not-burn for not only meeting but beating recent revenue estimates.
Earlier this year, the U.S. Food and Drug Administration (FDA) gave Altria approval to sell IQOS in the U.S. [read more here]. There are plans for IQOS to be released in Atlanta sometime this summer. PMI has been working with Altria to share how it introduced IQOS to the European market in hopes of making the rollout in the U.S. just as successful. Continued